HAART Annuloplasty Device Valve Repair Registry

NCT04035356 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 183

Last updated 2024-08-09

No results posted yet for this study

Summary

Multicenter US registry study to assess procedure success and long-term (10-year) performance of the HAART 200 and HAART 300 Aortic Annuloplasty Devices when used during aortic valve repair in a routine cardiovascular practice setting.

Conditions

  • Aortic Valve Insufficiency
  • Aortic Aneurysm

Interventions

DEVICE

Aortic valve repair

Use of a HAART Aortic Annuloplasty Device in patients undergoing aortic valve repair surgery

Sponsors & Collaborators

  • Biostable Science & Engineering

    lead INDUSTRY

Principal Investigators

  • J. Scott Rankin, MD · West Virginia University Heart and Vascular Institute

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-22
Primary Completion
2024-07-25
Completion
2024-07-25
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04035356 on ClinicalTrials.gov